BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9344471)

  • 1. Hydrophobic ion pairing as a method for enhancing structure and activity of lyophilized subtilisin BPN' suspended in isooctane.
    Kendrick BS; Meyer JD; Matsuura JE; Carpenter JF; Manning MC
    Arch Biochem Biophys; 1997 Nov; 347(1):113-8. PubMed ID: 9344471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of secondary structure on the activity of enzymes suspended in organic solvents.
    Dong A; Meyer JD; Kendrick BS; Manning MC; Carpenter JF
    Arch Biochem Biophys; 1996 Oct; 334(2):406-14. PubMed ID: 8900418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of calcium-independent subtilisin BPN' with restored thermal stability folded without the prodomain.
    Almog O; Gallagher T; Tordova M; Hoskins J; Bryan P; Gilliland GL
    Proteins; 1998 Apr; 31(1):21-32. PubMed ID: 9552156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catalytic activity and conformation of chemically modified subtilisin Carlsberg in organic media.
    Kwon OH; Imanishi Y; Ito Y
    Biotechnol Bioeng; 1999; 66(4):265-70. PubMed ID: 10578097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folding of subtilisin BPN': characterization of a folding intermediate.
    Eder J; Rheinnecker M; Fersht AR
    Biochemistry; 1993 Jan; 32(1):18-26. PubMed ID: 8418836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of crown ethers on structure, stability, activity, and enantioselectivity of subtilisin Carlsberg in organic solvents.
    Santos AM; Vidal M; Pacheco Y; Frontera J; Báez C; Ornellas O; Barletta G; Griebenow K
    Biotechnol Bioeng; 2001 Aug; 74(4):295-308. PubMed ID: 11410854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designing subtilisin BPN' to cleave substrates containing dibasic residues.
    Ballinger MD; Tom J; Wells JA
    Biochemistry; 1995 Oct; 34(41):13312-9. PubMed ID: 7577915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tertiary structure formation in the propeptide of subtilisin BPN' by successive amino acid replacements and its close relation to function.
    Kojima S; Minagawa T; Miura K
    J Mol Biol; 1998 Apr; 277(5):1007-13. PubMed ID: 9571018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of soluble and active subtilisin and alpha-chymotrypsin in organic solvents via hydrophobic ion pairing.
    Meyer JD; Kendrick BS; Matsuura JE; Ruth JA; Bryan PN; Manning MC
    Int J Pept Protein Res; 1996 Mar; 47(3):177-81. PubMed ID: 8740967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folding of subtilisin BPN': role of the pro-sequence.
    Eder J; Rheinnecker M; Fersht AR
    J Mol Biol; 1993 Sep; 233(2):293-304. PubMed ID: 8377204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obtaining higher transesterification rates with subtilisin Carlsberg in nonaqueous media.
    Roy I; Sharma A; Gupta MN
    Bioorg Med Chem Lett; 2004 Feb; 14(4):887-9. PubMed ID: 15012987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic studies of the inhibitory effects of propeptides subtilisin BPN' and Carlsberg to bacterial serine proteases.
    Huang HW; Chen WC; Wu CY; Yu HC; Lin WY; Chen ST; Wang KT
    Protein Eng; 1997 Oct; 10(10):1227-33. PubMed ID: 9488148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MD simulation of subtilisin BPN' in a crystal environment.
    Heiner AP; Berendsen HJ; van Gunsteren WF
    Proteins; 1992 Dec; 14(4):451-64. PubMed ID: 1438183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydration of enzyme in nonaqueous media is consistent with solvent dependence of its activity.
    Yang L; Dordick JS; Garde S
    Biophys J; 2004 Aug; 87(2):812-21. PubMed ID: 15298890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme engineering for nonaqueous solvents. II. Additive effects of mutations on the stability and activity of subtilisin E in polar organic media.
    Chen KQ; Robinson AC; Van Dam ME; Martinez P; Economou C; Arnold FH
    Biotechnol Prog; 1991; 7(2):125-9. PubMed ID: 1367168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation and stabilization of stabilisins in neat organic solvents.
    Schulze B; Klibanov AM
    Biotechnol Bioeng; 1991 Nov; 38(9):1001-6. PubMed ID: 18600863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The refined crystal structure of subtilisin Carlsberg at 2.5 A resolution.
    Neidhart DJ; Petsko GA
    Protein Eng; 1988 Oct; 2(4):271-6. PubMed ID: 3150541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing the salt-induced activation of enzymes in organic solvents: effects of lyophilization time and water content.
    Ru MT; Dordick JS; Reimer JA; Clark DS
    Biotechnol Bioeng; 1999 Apr; 63(2):233-41. PubMed ID: 10099600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prosegment-subtilisin BPN' complex: crystal structure of a specific 'foldase'.
    Gallagher T; Gilliland G; Wang L; Bryan P
    Structure; 1995 Sep; 3(9):907-14. PubMed ID: 8535784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refined crystal structure of the complex of subtilisin BPN' and Streptomyces subtilisin inhibitor at 1.8 A resolution.
    Takeuchi Y; Satow Y; Nakamura KT; Mitsui Y
    J Mol Biol; 1991 Sep; 221(1):309-25. PubMed ID: 1920411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.